DCW DCW Q3 FY26 results (Oct–Dec 2025) and concall
DCW delivered a resilient operating performance in Q3 FY26 amidst a challenging global chemical industry marked by pricing pressure and uneven demand. The company achieved approximately 9.6% YoY revenue growth, primarily driven by strong volume momentum in Specialty Chemicals, which saw a 27% revenue increase. While Basic Chemicals faced significant margin pressure due to price erosion, the Specialty segment's strong performance and strategic portfolio rebalancing helped offset the weakness, leading to a 14% YoY improvement in 9-month EBITDA.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 9.7%, net profit down 61.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 489 | 474 | 538 | 476 | 539 +10% | 520 +10% |
| EBITDA | 35 | 57 | 56 | 54 | 58 +66% | 45 −21% |
| Net profit | -1 | 13 | 11 | 11 | 14 +1500% | 5 −62% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
